bradykinin

简明释义

英[ˌbrædɪˈkaɪnɪn]美[ˈbrædiˈkaɪnɪn]

n. [生化] 缓激肽；徐缓激肽；[生化] 血管舒缓激肽

英英释义

单词用法

同义词

反义词

例句

1.Methods to determine whether the expression of bradykinin B2 receptor are on the vascular endothelial cell or cerebral glioma cell, double immunohistochemistry was used.

方法通过双重免疫组化染色，确定缓激肽b 2受体是存在于血管内皮细胞上还是存在于肿瘤细胞上。

2.Therefore, it is possible that renal tissue kallikrein-bradykinin system is also released and activated by the stimulation of inflammation in sepsis.

因此，肾脏的组织型血管增渗酶也有可能被败血症引发的发炎反应刺激而释放出来，并产生作用。

3.When targeted by the bradykinin, these proteins then cause the nerve cells to send electrical 'pain' signals to the brain.

当缓激肽作用于目标，这些蛋白质则导致神经细胞发出电子'痛苦'的信号给大脑。

4.Bradykinin is a very powerful endothelium - dependent vasodilator and this is very important for clinicians.

缓激肽是一种效力很强的内皮依赖性血管舒张剂，也是临床医生的常用药。

5.Objective To observe the effect of bradykinin(BK) on kidney mesangial cell multiplication and extracellular matrix secretion under high glucose environment.

目的观察缓激肽（BK）对高糖浓度下肾小球系膜细胞增殖和细胞外基质分泌的影响。

6.Objective To investigate the effect of bradykinin (BK) on tight junction (TJ) of the blood-tumor barrier (BTB) and interendothelial TJ of capillaries in brain glioma rats.

目的研究缓激肽（BK）对脑胶质瘤大鼠血肿瘤屏障紧密连接的影响。

7.Objective To investigate the effect of bradykinin (BK) on tight junction (TJ) of the blood-tumor barrier (BTB) and interendothelial TJ of capillaries in brain glioma rats.

目的研究缓激肽（BK）对脑胶质瘤大鼠血肿瘤屏障紧密连接的影响。

8.Research shows that bradykinin may play a role in pain signaling.

研究表明，缓激肽可能在疼痛信号传递中发挥作用。

9.The release of bradykinin is a key factor in the inflammatory response.

释放缓激肽是炎症反应中的一个关键因素。

10.Certain medications can inhibit the action of bradykinin to reduce swelling.

某些药物可以抑制缓激肽的作用以减少肿胀。

11.During an allergic reaction, bradykinin levels can increase significantly.

在过敏反应中，缓激肽水平可能显著增加。

12.Increased levels of bradykinin are associated with various cardiovascular diseases.

升高的缓激肽水平与多种心血管疾病相关。

作文

Bradykinin is a peptide that plays a significant role in various physiological processes within the human body. It is primarily known for its ability to induce vasodilation, which is the widening of blood vessels. This function is crucial for regulating blood pressure and ensuring adequate blood flow to tissues. When bradykinin is released, it binds to specific receptors on the surface of endothelial cells, leading to the production of nitric oxide, a potent vasodilator. This mechanism illustrates how bradykinin can influence cardiovascular health and response to injury. In addition to its effects on blood vessels, bradykinin (缓激肽) is also involved in pain signaling. It is released during inflammation and can sensitize nerve endings, making them more responsive to stimuli. This process can result in the perception of pain, which serves as a protective mechanism to alert the body to potential harm. Understanding the role of bradykinin (缓激肽) in pain pathways has implications for developing new analgesic medications aimed at managing chronic pain conditions. Moreover, bradykinin (缓激肽) is implicated in various pathological conditions. For instance, it has been linked to asthma and other respiratory disorders due to its ability to cause bronchoconstriction, or the narrowing of air passages. In these contexts, elevated levels of bradykinin (缓激肽) can exacerbate symptoms and lead to increased difficulty in breathing. Therefore, targeting bradykinin (缓激肽) pathways may offer therapeutic avenues for treating such diseases. The study of bradykinin (缓激肽) extends into the realm of pharmacology, where researchers are exploring its potential as a target for drug development. Certain inhibitors that block the action of bradykinin (缓激肽) have shown promise in clinical settings, particularly for conditions characterized by excessive inflammation or pain. By modulating the effects of bradykinin (缓激肽), it may be possible to alleviate symptoms and improve quality of life for patients suffering from a variety of ailments. In conclusion, bradykinin (缓激肽) is a multifaceted peptide with critical roles in cardiovascular function, pain perception, and inflammatory responses. Its diverse effects make it a key player in both health and disease, underscoring the importance of continued research in this area. As we deepen our understanding of bradykinin (缓激肽) and its mechanisms, we open the door to innovative therapeutic strategies that could transform the management of numerous medical conditions. The exploration of bradykinin (缓激肽) continues to be a vibrant field of study, promising new insights into human physiology and potential treatments for various diseases.

缓激肽是一种在人体内发挥重要作用的肽。它主要以诱导血管舒张而闻名，血管舒张是指血管的扩张。这一功能对于调节血压和确保组织的适当血流至关重要。当缓激肽释放时，它会与内皮细胞表面的特定受体结合，从而导致一氧化氮的产生，而一氧化氮是一种强效的血管舒张剂。这一机制说明了缓激肽如何影响心血管健康及对损伤的反应。除了对血管的影响，缓激肽还参与疼痛信号传递。它在炎症过程中释放，并能使神经末梢敏感，使其对刺激的反应增强。这一过程可能导致疼痛的感知，这是一个保护机制，用于警告身体潜在的伤害。理解缓激肽在疼痛通路中的作用对开发新的镇痛药物以管理慢性疼痛状况具有重要意义。此外，缓激肽还与各种病理状态相关。例如，由于其能够引起支气管收缩，缓激肽与哮喘和其他呼吸系统疾病有关。在这些情况下，缓激肽的水平升高可能加重症状并导致呼吸困难。因此，针对缓激肽通路可能为治疗此类疾病提供治疗途径。缓激肽的研究延伸到药理学领域，研究人员正在探索其作为药物开发目标的潜力。某些抑制剂能够阻断缓激肽的作用，在临床环境中显示出希望，特别是对于以过度炎症或疼痛为特征的疾病。通过调节缓激肽的效果，可能有助于减轻症状并提高患者的生活质量。总之，缓激肽是一种多面向的肽，在心血管功能、疼痛感知和炎症反应中扮演着关键角色。其多样化的效果使其成为健康和疾病中的关键角色，突显了在这一领域继续研究的重要性。随着我们对缓激肽及其机制的深入理解，我们为创新治疗策略打开了大门，这些策略可能会改变许多医疗条件的管理。对缓激肽的探索仍然是一个充满活力的研究领域，承诺为人类生理学和各种疾病的潜在治疗提供新的见解。